Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1980 2
1981 1
1982 2
1983 2
1984 4
1985 1
1986 1
1987 1
1988 4
1989 1
1991 4
1992 3
1993 3
1994 8
1995 6
1996 4
1997 5
1998 4
1999 8
2000 6
2001 10
2002 7
2003 3
2004 10
2005 6
2006 8
2007 8
2008 10
2009 3
2010 6
2011 11
2012 11
2013 11
2014 11
2015 14
2016 7
2017 5
2018 7
2019 3
2020 3
2021 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

214 results

Results by year

Filters applied: . Clear all
Page 1
Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse.
Taavitsainen S, Engedal N, Cao S, Handle F, Erickson A, Prekovic S, Wetterskog D, Tolonen T, Vuorinen EM, Kiviaho A, Nätkin R, Häkkinen T, Devlies W, Henttinen S, Kaarijärvi R, Lahnalampi M, Kaljunen H, Nowakowska K, Syvälä H, Bläuer M, Cremaschi P, Claessens F, Visakorpi T, Tammela TLJ, Murtola T, Granberg KJ, Lamb AD, Ketola K, Mills IG, Attard G, Wang W, Nykter M, Urbanucci A. Taavitsainen S, et al. Among authors: visakorpi t. Nat Commun. 2021 Sep 6;12(1):5307. doi: 10.1038/s41467-021-25624-1. Nat Commun. 2021. PMID: 34489465 Free PMC article.
The evolutionary history of lethal metastatic prostate cancer.
Gundem G, Van Loo P, Kremeyer B, Alexandrov LB, Tubio JMC, Papaemmanuil E, Brewer DS, Kallio HML, Högnäs G, Annala M, Kivinummi K, Goody V, Latimer C, O'Meara S, Dawson KJ, Isaacs W, Emmert-Buck MR, Nykter M, Foster C, Kote-Jarai Z, Easton D, Whitaker HC; ICGC Prostate Group; Neal DE, Cooper CS, Eeles RA, Visakorpi T, Campbell PJ, McDermott U, Wedge DC, Bova GS. Gundem G, et al. Among authors: visakorpi t. Nature. 2015 Apr 16;520(7547):353-357. doi: 10.1038/nature14347. Epub 2015 Apr 1. Nature. 2015. PMID: 25830880 Free PMC article.
Identification of long noncoding RNAs with aberrant expression in prostate cancer metastases.
Sattari M, Kohvakka A, Moradi E, Rauhala H, Urhonen H, Isaacs WB, Nykter M, Murtola TJ, Tammela TLJ, Latonen L, Bova GS, Kesseli J, Visakorpi T. Sattari M, et al. Among authors: visakorpi t. Endocr Relat Cancer. 2023 Jun 26;30(8):e220247. doi: 10.1530/ERC-22-0247. Print 2023 Aug 1. Endocr Relat Cancer. 2023. PMID: 37140987 Free PMC article.
Molecular mechanisms of prostate cancer.
Porkka KP, Visakorpi T. Porkka KP, et al. Among authors: visakorpi t. Eur Urol. 2004 Jun;45(6):683-91. doi: 10.1016/j.eururo.2004.01.012. Eur Urol. 2004. PMID: 15149739 Review.
PARP-1 regulates DNA repair factor availability.
Schiewer MJ, Mandigo AC, Gordon N, Huang F, Gaur S, de Leeuw R, Zhao SG, Evans J, Han S, Parsons T, Birbe R, McCue P, McNair C, Chand SN, Cendon-Florez Y, Gallagher P, McCann JJ, Poudel Neupane N, Shafi AA, Dylgjeri E, Brand LJ, Visakorpi T, Raj GV, Lallas CD, Trabulsi EJ, Gomella LG, Dicker AP, Kelly WK, Leiby BE, Knudsen B, Feng FY, Knudsen KE. Schiewer MJ, et al. Among authors: visakorpi t. EMBO Mol Med. 2018 Dec;10(12):e8816. doi: 10.15252/emmm.201708816. EMBO Mol Med. 2018. PMID: 30467127 Free PMC article.
Molecular genetics of prostate cancer.
Elo JP, Visakorpi T. Elo JP, et al. Among authors: visakorpi t. Ann Med. 2001 Mar;33(2):130-41. doi: 10.3109/07853890109002068. Ann Med. 2001. PMID: 11327116 Review.
Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES, Böttcher R, Croce CM, Jenster G, Visakorpi T, Calin GA. Martens-Uzunova ES, et al. Among authors: visakorpi t. Eur Urol. 2014 Jun;65(6):1140-51. doi: 10.1016/j.eururo.2013.12.003. Epub 2013 Dec 14. Eur Urol. 2014. PMID: 24373479 Review.
Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine.
Nurminen A, Jaatinen S, Taavitsainen S, Högnäs G, Lesluyes T, Ansari-Pour N, Tolonen T, Haase K, Koskenalho A, Kankainen M, Jasu J, Rauhala H, Kesäniemi J, Nikupaavola T, Kujala P, Rinta-Kiikka I, Riikonen J, Kaipia A, Murtola T, Tammela TL, Visakorpi T, Nykter M, Wedge DC, Van Loo P, Bova GS. Nurminen A, et al. Among authors: visakorpi t. Genome Med. 2023 Oct 12;15(1):82. doi: 10.1186/s13073-023-01242-y. Genome Med. 2023. PMID: 37828555 Free PMC article.
Alterations of androgen receptor in prostate cancer.
Linja MJ, Visakorpi T. Linja MJ, et al. Among authors: visakorpi t. J Steroid Biochem Mol Biol. 2004 Nov;92(4):255-64. doi: 10.1016/j.jsbmb.2004.10.012. Epub 2004 Dec 19. J Steroid Biochem Mol Biol. 2004. PMID: 15663988 Review.
The role of genetic markers in the management of prostate cancer.
Choudhury AD, Eeles R, Freedland SJ, Isaacs WB, Pomerantz MM, Schalken JA, Tammela TL, Visakorpi T. Choudhury AD, et al. Among authors: visakorpi t. Eur Urol. 2012 Oct;62(4):577-87. doi: 10.1016/j.eururo.2012.05.054. Epub 2012 Jun 5. Eur Urol. 2012. PMID: 22695242 Review.
214 results